An in silico approach to map the binding site of doxorubicin on hemoglobin.
Binding modalities of doxorubicin (DOX), a widely used antineoplastic anthracyline antibiotic with hemoglobin (Hb) have been studied. The protein and the ligand were prepared using CORINA and protonated with insight II. The best conformation was sought by employing GOLDV. Molecular modeling calculations showed that DOX binds Hb to a non-classical drug binding site. The alpha subunit of Hb has been assigned to posses the binding site for DOX with a binding affinity (Ka) = 16.98 x10(3) mol(-1). The interaction was found to be thermodynamically favorable (DeltaG degrees = -66.23 KJmol(-1)). The analysis of DOX binding site to Hb suggested that the types of interactions that contribute in this binding are hydrophobic contacts, hydrogen bonding and electrostatic interactions.
Khan
Shahper Nazeer
SN
Interdisciplinary Biotechnology Unit, Aligarh Muslim University, Aligarh-202002, India.
Khan
Asad Ullah
AU
J Comput Aided Mol Des. 2002 Nov;16(11):795-801
12825791
J Colloid Interface Sci. 2006 Apr 1;296(1):324-31
16225884
Chem Biol Interact. 1972 May;4(6):409-19
5030586
Curr Opin Allergy Clin Immunol. 2001 Aug;1(4):317-25
11964707
Biochim Biophys Acta. 1998 Mar 6;1370(1):31-40
9518541
Hemoglobin. 1980;4(5-6):735-45
6254923
Biochem J. 1979 Jun 1;179(3):665-73
475774
Blood. 1978 Nov;52(5):878-85
698394
Adv Colloid Interface Sci. 2005 Nov 30;116(1-3):111-20
16099417
Braz J Med Biol Res. 2003 Dec;36(12):1643-51
14666248
J Biol Chem. 1962 Apr;237:1319-22
14473857
J Mol Biol. 1982 Oct 25;161(2):269-88
7154081
Am J Hematol. 1979;7(2):97-106
539595
Tohoku J Exp Med. 2007 Sep;213(1):1-16
17785948
Annu Rev Pharmacol Toxicol. 1997;37:91-117
9131248
Crit Rev Oncol Hematol. 1991;11(1):43-64
1831987